secwatch.observer — SEC 8-K summary
======================================

Issuer:     Enveric Biosciences, Inc. (ENVB)
CIK:        0000890821
Form:       8-K
Filed at:   2024-02-09T23:59:59+00:00
Accession:  0001493152-24-005561
Event type: regulatory
Sentiment:  neutral
Materiality: 0.60
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Enveric Biosciences gets Nasdaq extension to meet $2.5M equity requirement by May 20, 2024
--------------------------------------------------------------------------------

- Nasdaq granted extension to May 20, 2024 to meet minimum $2,500,000 stockholders' equity requirement.
- If compliance not evidenced by May 20, 2024, Nasdaq may issue delisting notice.
- Additional compliance deadline: filing of periodic report for June 30, 2024; failure may lead to delisting.
- Company states it plans to regain compliance with the equity requirement.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/890821/000149315224005561/0001493152-24-005561-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/890821/000149315224005561/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-005561

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer